搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Plasmodium falciparum Glycophorin-binding protein (GBP), partial CSB-YP815517EWP
CSB-EP815517EWP
CSB-BP815517EWP
CSB-MP815517EWP
CSB-EP815517EWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Odorant response abnormal protein 4 (odr-4), partial CSB-YP815518CXY1
CSB-EP815518CXY1
CSB-BP815518CXY1
CSB-MP815518CXY1
CSB-EP815518CXY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porcellio scaber Androgenic gland hormone (AGH) CSB-YP815519PJAZ
CSB-EP815519PJAZ
CSB-BP815519PJAZ
CSB-MP815519PJAZ
CSB-EP815519PJAZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Metallothionein-4 (MtnD) CSB-YP815520DLU
CSB-EP815520DLU
CSB-BP815520DLU
CSB-MP815520DLU
CSB-EP815520DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Plasmodium falciparum U1 small nuclear ribonucleoprotein C (PF08_0084) CSB-YP815521EWP
CSB-EP815521EWP
CSB-BP815521EWP
CSB-MP815521EWP
CSB-EP815521EWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Plasmodium falciparum Calcium-dependent protein kinase 4 (CPK4), partial CSB-YP815522EWP
CSB-EP815522EWP
CSB-BP815522EWP
CSB-MP815522EWP
CSB-EP815522EWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Plasmodium falciparum Uncharacterized protein MAL13P1.304 (MAL13P1.304), partial CSB-YP815523EWP
CSB-EP815523EWP
CSB-BP815523EWP
CSB-MP815523EWP
CSB-EP815523EWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Scutigera coleoptrata Hemocyanin subunit B (HCB), partial CSB-YP815524SIAV
CSB-EP815524SIAV
CSB-BP815524SIAV
CSB-MP815524SIAV
CSB-EP815524SIAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Plasmodium falciparum Coiled-coil domain-containing protein PF11_0455 (PF11_0455) CSB-YP815525EWP
CSB-EP815525EWP
CSB-BP815525EWP
CSB-MP815525EWP
CSB-EP815525EWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Plasmodium falciparum Enolase (ENO) CSB-YP815526EWP
CSB-EP815526EWP
CSB-BP815526EWP
CSB-MP815526EWP
CSB-EP815526EWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Plasmodium falciparum Uncharacterized protein PF14_0397 (PF14_0397) CSB-YP815527EWP
CSB-EP815527EWP
CSB-BP815527EWP
CSB-MP815527EWP
CSB-EP815527EWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Plasmodium falciparum Uncharacterized protein PF14_0093 (PF14_0093), partial CSB-YP815528EWP
CSB-EP815528EWP
CSB-BP815528EWP
CSB-MP815528EWP
CSB-EP815528EWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Protein SPT2 homolog (CG5815), partial CSB-YP815529DLU
CSB-EP815529DLU
CSB-BP815529DLU
CSB-MP815529DLU
CSB-EP815529DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Putative gustatory receptor 92a (Gr92a), partial CSB-YP815530DLU1
CSB-EP815530DLU1
CSB-BP815530DLU1
CSB-MP815530DLU1
CSB-EP815530DLU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Methionine-R-sulfoxide reductase B1 (SelR) CSB-YP815531DLU
CSB-EP815531DLU
CSB-BP815531DLU
CSB-MP815531DLU
CSB-EP815531DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Protein TIPIN homolog (CG10336) CSB-YP815532DLU
CSB-EP815532DLU
CSB-BP815532DLU
CSB-MP815532DLU
CSB-EP815532DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Complexin (cpx) CSB-YP815533DLU
CSB-EP815533DLU
CSB-BP815533DLU
CSB-MP815533DLU
CSB-EP815533DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Uncharacterized FAM18-like protein CG5021 (CG5021), partial CSB-YP815534DLU1
CSB-EP815534DLU1
CSB-BP815534DLU1
CSB-MP815534DLU1
CSB-EP815534DLU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster LIM/homeobox protein Awh (Awh) CSB-YP815535DLU
CSB-EP815535DLU
CSB-BP815535DLU
CSB-MP815535DLU
CSB-EP815535DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Putative gustatory receptor 9a (Gr9a), partial CSB-YP815536DLU1
CSB-EP815536DLU1
CSB-BP815536DLU1
CSB-MP815536DLU1
CSB-EP815536DLU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>